Stonepine Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-100,000
Closed -$415K – 75
2025
Q2
$415K Buy
+100,000
New +$626K 0.41% 44

Other funds holding VSTM

Stonepine Capital Management's VSTM Position: Q2 2026 in Review

Stonepine Capital Management increased its Verastem (VSTM) stake by 1.4% in Q2 2026, buying an estimated $229K and bringing the position to 3,349,627 shares worth $12.8M. The position accounts for 7.22% of the portfolio, ranked #1.

Stonepine Capital Management first reported a position in VSTM in Q4 2017 and has held it in 10 quarters since. The position peaked at $23.6M in Q3 2025. 156 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Stonepine Capital Management held 3,349,627 shares of Verastem worth $12.8M as of Q2 2026.
  • Stonepine Capital Management bought 47,327 Verastem shares in Q2 2026, an estimated $229K.
  • Verastem made up 7.22% of Stonepine Capital Management's portfolio in Q2 2026, its #1 holding.
  • Stonepine Capital Management first reported a position in Verastem in Q4 2017 and has held it in 10 quarters since.
  • Stonepine Capital Management's Verastem position peaked at $23.6M in Q3 2025.
  • 156 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.